AN OPEN-LABEL INTERNATIONAL PHASE III STUDY OF THE LONG-TERM SAFETY OF LIPROTAMASE FOR TREATMENT OF PANCREATIC INSUFFICIENCY IN CF

被引：0
|
作者：
Borowitz, D. [1 ]
Stevens, C. [2 ]
Fratazzi, C. [2 ]
Cohen, D. [2 ]
Campion, M. [2 ]
机构：
[1] SUNY Buffalo, Womens & Childrens Hosp, Dept Pediat, Buffalo, NY 14260 USA
[2] Alnara Pharmaceut Inc, Cambridge, MA USA
来源：
PEDIATRIC PULMONOLOGY | 2009年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
520
引用
收藏
页码：397 / 398
页数：2
相关论文
共 50 条
  • [41] A long-term, open-label study of valbenazine for tardive dyskinesia
    Lindenmayer, Jean-Pierre
    Verghese, Cherian
    Marder, Stephen R.
    Burke, Joshua
    Jimenez, Roland
    Siegert, Scott
    Liang, Grace S.
    O'Brien, Christopher F.
    CNS SPECTRUMS, 2021, 26 (04) : 345 - 353
  • [42] Long-Term Safety, Tolerability, and Efficacy of Atogepant for the Preventive Treatment of Migraine: Interim Analysis of a Phase 3, Multicenter, Open-Label, 156-Week Long-Term Safety Extension Study
    Ashina, Sait
    Ashina, Messoud
    Holle-Lee, Dagny
    Tassorelli, Cristina
    Cho, Soo-Jin
    He, Molly Yizeng
    Ferreira, Rosa De Abreu
    Smith, Jonathan H.
    Pfleeger, Kimberly
    Trugman, Joel
    NEUROLOGY, 2024, 102 (12) : S7 - S8
  • [43] Difamilast Ointment in Japanese Adult and Pediatric Patients with Atopic Dermatitis: A Phase III, Long-Term, Open-Label Study
    Saeki, Hidehisa
    Imamura, Tomomi
    Yokota, Daisuke
    Tsubouchi, Hidetsugu
    DERMATOLOGY AND THERAPY, 2022, 12 (07) : 1589 - 1601
  • [44] Difamilast Ointment in Japanese Adult and Pediatric Patients with Atopic Dermatitis: A Phase III, Long-Term, Open-Label Study
    Hidehisa Saeki
    Tomomi Imamura
    Daisuke Yokota
    Hidetsugu Tsubouchi
    Dermatology and Therapy, 2022, 12 : 1589 - 1601
  • [45] An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients
    Ersoy, Mehmet A.
    Noyan, Aysin M.
    Elbi, Hayriye
    CLINICAL DRUG INVESTIGATION, 2008, 28 (02) : 113 - 120
  • [46] Zanaflex® treatment of spasticity in patients with multiple sclerosis:: A long-term, open-label study
    Stazio, A
    Groves, L
    Hudson, S
    NEUROLOGY, 1998, 50 (04) : A147 - A147
  • [47] Long-term treatment with zonisamide: Results of a 2 year open-label extension study
    Wroe, S.
    Duncan, R.
    EPILEPSIA, 2006, 47 : 138 - 138
  • [48] A Phase 3, Long-Term, Open-Label Safety Study of Self-Administered Galcanezumab Injections in Patients with Migraine
    Stauffer, Virginia L.
    Sides, Ryan
    Camporeale, Angelo
    Skljarevski, Vladimir
    Ahl, Jonna
    Aurora, Sheena K.
    CEPHALALGIA, 2017, 37 : 330 - 331
  • [49] A Phase 2, Open-label Extension Study to Evaluate Long-term Safety of Anifrolumab in Adults with Systemic Lupus Erythematosus
    Chatham, W. Winn
    Furie, Richard
    Saxena, Amit
    Brohawn, Philip
    Schwetje, Erik
    Abreu, Gabriel
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [50] An Open-Label Long-Term Naturalistic Study of Mirtazapine Treatment for Depression in Cancer Patients
    Mehmet A. Ersoy
    Aysin M. Noyan
    Hayriye Elbi
    Clinical Drug Investigation, 2008, 28 : 113 - 120
12345